Search

Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.

… Tuesday, October 4, 2022 Today Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award. Dr. Gitlin was chosen for his outstanding work and proposal

MSK's Robert Motzer presented positive data from a phase III randomized study that assessed two different treatment combinations as first-line therapies that may benefit people with advanced kidney cancer.

… Monday, February 15, 2021 Update: On August 11, 2021, the FDA approved pembrolizumab (Keytruda®) plus lenvatinib (Lenvima®) for first-line treatments for patients with advanced renal cell carcinoma (RCC). Memorial Sloan Kettering Cancer Center (MSK) physicians and scientists presented new research at

Pediatric oncologists from around the world will gather in Lyon, France, from October 23 through 26, for the International Society of Paediatric Oncology’s annual meeting. Featuring new research and important discoveries — many led by MSK Kids researchers — the meeting will highlight the latest in the fields of pediatric oncology, including blood cancer, sarcoma, Wilms’ tumor, genomics, radiation oncology, and neuroblastoma.

… Tuesday, October 22, 2019 Pediatric oncologists from around the world will gather in Lyon, France, from October 23 through 26, for the International Society of Paediatric Oncology’s annual meeting. Featuring new research and important discoveries — many led by MSK Kids researchers — the meeting will

Learn how to control weight gain during and after breast cancer treatment, from experts at MSK.

… Tuesday, August 12, 2025 Advances in breast cancer treatment mean more people than ever are surviving. There are nearly 4 million people living with breast cancer in the United States, and that number will continue to grow, thanks to lifesaving therapies. People diagnosed with breast cancer can help

The inaugural Kravis WiSE Symposium will take place virtually July 8-20, 2020. Each talk will be broadcast as part of the MSK Science Spotlight series, which is available via livestream and open to all.

… Tuesday, July 7, 2020 MSK has recently announced the establishment of the Marie-Josée Kravis Women in Science Endeavor ( WISE ) to provide financial and professional support to women scientists pursuing biomedical research at MSK, pledging its commitment to gender equity in science and paving the way

New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new insights into joint inflammation in rheumatoid arthritis; developed a systems-level platform called epichaperomics to map changes in interactors among thousands of proteins involved in cancer-related processes; and investigated how artificial intelligence could help diagnose an invasive form of breast cancer.

… Thursday, June 29, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  and the  Sloan Kettering Institute  — a hub for basic science and translational research within MSK — discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers

MSK has joined with 68 of the nation’s top cancer centers in issuing a statement urging increased HPV vaccination for the prevention of cancer. This statement, signed by MSK Physician-in-Chief and Chief Medical Officer José Baslega, MD, PhD, and colleagues at NCI-designated cancer centers across the country, calls upon the nation’s physicians, parents, and young adults to take advantage of this rare opportunity to prevent many types of cancer. MSK head and neck and gynecologic cancer experts are available to discuss the importance of the HPV vaccine and risks of HPV-related cancers. Please email [email protected] to arrange an interview.

… Wednesday, January 27, 2016 MSK has joined with 68 of the nation’s top cancer centers in issuing a statement urging increased HPV vaccination for the prevention of cancer. This statement, signed by MSK Physician-in-Chief and Chief Medical Officer José Baslega, MD, PhD, and colleagues at NCI-designated

Minimally invasive surgery (MIS) to resect liver segments 7 and 8 is safe for select patients treated by experienced MIS hepatopancreatobiliary surgeons.

… Tuesday, March 2, 2021 Minimally invasive surgery (MIS) to resect liver segments 7 and 8 is safe for select patients treated by experienced MIS hepatopancreatobiliary surgeons, according to our retrospective study published recently in the Journal of Surgical Oncology .  (1) Whether MIS is a safe and

Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.

… Wednesday, January 17, 2018 Summary A new finding suggests that a genetic mistake in cancer cells known as chromosomal instability creates an inflammatory state within the cells. The cancer cells take advantage of this condition by hijacking pathways used by immune cells to migrate. This enables these

Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute, Inc., a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan Kettering Cancer Center.

… Thursday, December 5, 2013 Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute , Inc. (Tri-I TDI), a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan Kettering Cancer Center that is designed to